Who owns CARDIFF ONCOLOGY INC COM?
- Ticker: CRDF
- CUSIP Number: 14147l108
Tip: Access positions for across all investors
Analyze quarterly positions in Cardiff Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cardiff Oncology stock
Who bought or sold CARDIFF ONCOLOGY INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.9M | $10M | 0% | Mar 2024 |
|
| Laurion Capital Management | 929k | $5.0M | 29% | Mar 2024 |
|
| Millennium Management | 683k | $3.6M | 100% | Mar 2024 |
|
| BlackRock | 678k | $3.6M | -6% | Mar 2024 |
|
| UBS Group | 636k | $3.4M | 18856% | Mar 2024 |
|
| MAI Wealth Advisors | 551k | $2.9M | 45% | Mar 2024 |
|
| Geode Capital Management | 435k | $2.3M | 11% | Mar 2024 |
|
| Marshall Wace | 435k | $2.3M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 286k | $1.5M | 100% | Mar 2024 |
|
| Assenagon Asset Management | 253k | $1.4M | 100% | Mar 2024 |
|
| Susquehanna International | 202k | $1.1M | -30% | Mar 2024 |
|
| William Blair $ Company | 172k | $919k | 32% | Mar 2024 |
|
| Eudaimonia Asset Management | 162k | $865k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 127k | $680k | 244675% | Mar 2024 |
|
| Man Group | 113k | $602k | 100% | Mar 2024 |
|
| Northern Trust | 86k | $457k | 20% | Mar 2024 |
|
| Citigroup | 83k | $444k | 100% | Mar 2024 |
|
| Morgan Stanley | 79k | $424k | 318% | Mar 2024 |
|
| Jane Street | 72k | $386k | 233% | Mar 2024 |
|
| Hrt Financial | 68k | $362k | 100% | Mar 2024 |
|
| Bank of America Corporation | 65k | $346k | 30% | Mar 2024 |
|
| Wolverine Trading | 55k | $294k | 100% | Mar 2024 |
|
| Capstone Investment Advisors | 51k | $273k | 0% | Mar 2024 |
|
| Point72 Asia | 50k | $266k | 100% | Mar 2024 |
|
| Citadel Advisors | 46k | $247k | 27% | Mar 2024 |
|
| Callan Capital | 43k | $228k | 37% | Mar 2024 |
|
| Creative Planning | 40k | $215k | 58% | Mar 2024 |
|
| Elkhorn Partners Limited Partnership | 39k | $208k | -13% | Mar 2024 |
|
| Simplex Trading | 38k | $200k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 37k | $195k | 0% | Mar 2024 |
|
| Brevan Howard Capital Management | 32k | $173k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 32k | $172k | 100% | Mar 2024 |
|
| Y-Intercept | 30k | $157k | 100% | Mar 2024 |
|
| Two Sigma Investments | 23k | $123k | -25% | Mar 2024 |
|
| American Century Companies | 23k | $122k | 100% | Mar 2024 |
|
| Bank Of Montreal | 22k | $44k | 100% | Mar 2024 |
|
| Integrated Wealth Concepts | 22k | $118k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 22k | $116k | -45% | Mar 2024 |
|
| HighTower Advisors | 18k | $96k | 17% | Mar 2024 |
|
| Squarepoint Ops | 18k | $94k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 16k | $88k | 0% | Mar 2024 |
|
| Sherbrooke Park Advisers | 16k | $86k | 100% | Mar 2024 |
|
| FinDec Wealth Services | 16k | $85k | 0% | Mar 2024 |
|
| United Bank | 16k | $83k | 19% | Mar 2024 |
|
| Marathon Trading Investment Management | 15k | $80k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 15k | $80k | 3119% | Mar 2024 |
|
| Gladstone Institutional Advisory | 15k | $22k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 14k | $76k | 0% | Mar 2024 |
|
| LMR Partners | 13k | $70k | 100% | Mar 2024 |
|
| CTC Alternative Strategies | 12k | $66k | 100% | Mar 2024 |
|
| Denver Wealth Management | 12k | $65k | -40% | Mar 2024 |
|
| Group One Trading | 10k | $54k | -70% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 10k | $54k | 100% | Mar 2024 |
|
| PFG Investments | 10k | $53k | 100% | Mar 2024 |
|
| Tortoise Investment Management | 10k | $53k | -33% | Mar 2024 |
|
| Security National Bank | 9.8k | $52k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 7.8k | $42k | 0% | Mar 2024 |
|
| America First Investment Advisors | 4.0k | $21k | 0% | Mar 2024 |
|
| Tower Research Capital | 3.4k | $18k | 846% | Mar 2024 |
|
| Advisor Group Holdings | 1.8k | $9.8k | 0% | Mar 2024 |
|
| Pnc Financial Services | 1.5k | $8.1k | 0% | Mar 2024 |
|
| Moser Wealth Advisors | 806.00 | $4.3k | 0% | Mar 2024 |
|
| Eagle Bay Advisors | 339.00 | $1.8k | 0% | Mar 2024 |
|
| Us Bancorp | 109.00 | $581.994600 | 0% | Mar 2024 |
|
| Hanson McClain Advisors | 100.00 | $534.000000 | 0% | Mar 2024 |
|
| Goss Wealth Management | 81.00 | $433.001700 | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 48.00 | $255.998400 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 26.00 | $139.001200 | 0% | Mar 2024 |
|
| Newbridge Financial Services Group | 17.00 | $90.999300 | 0% | Mar 2024 |
|
| Cornerstone Planning Group | 5.00 | $18.000000 | 0% | Mar 2024 |
|
| Front Row Advisors | 2.00 | $11.000000 | 0% | Mar 2024 |
|
Who sold out of Cardiff Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Dec 2023 | 22k | $32k |
| Bank of New York Mellon | Dec 2023 | 14k | $21k |
| Two Sigma Securities | Dec 2023 | 11k | $16k |
| FMR | Sep 2023 | 1.6k | $2.2k |
| Fifth Third Bancorp | Dec 2023 | 200.00 | $296.000000 |